Skip to content

LIGAND PHARMACEUTICALS INC (LGND) Insider Trading -- Recent Executive & Director Transactions

10 insiders reported 240 Form 4 transactions for LIGAND PHARMACEUTICALS INC (LGND) over the past 18 months (most recent 2026-10-06). Recent activity: Reardon Andrew (CLO & Secretary) Buy 340 shares, Reardon Andrew (CLO & Secretary) Sell 833 shares, Reardon Andrew (CLO & Secretary) Sell 1,976 shares, Reardon Andrew (CLO & Secretary) Sell 1,535 shares, Reardon Andrew (CLO & Secretary) Sell 404 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-10-06Reardon AndrewCLO & SecretaryBuy340$17,772
2026-10-06Reardon AndrewCLO & SecretarySell833$251,991
2026-10-06Reardon AndrewCLO & SecretarySell1,976$599,804
2026-10-06Reardon AndrewCLO & SecretarySell1,535$467,431
2026-10-06Reardon AndrewCLO & SecretarySell404$123,698
2026-10-06Reardon AndrewCLO & SecretarySell235$72,190
2026-10-06Reardon AndrewCLO & SecretarySell17$5,232
2026-09-24Zimmermann MartineDirectorSell115$34,328
2026-09-14Zimmermann MartineDirectorSell1,200$342,000
2026-09-08Reardon AndrewCLO & SecretarySell385$110,697
2026-09-08Reardon AndrewCLO & SecretarySell1,800$513,301
2026-09-08Reardon AndrewCLO & SecretarySell2,115$605,649
2026-09-08Reardon AndrewCLO & SecretarySell300$85,196
2026-09-08Reardon AndrewCLO & SecretarySell400$115,592
2026-08-14Haas JasonDirectorBuy6,138$316,475
2026-08-14Espinoza OctavioChief Financial OfficerBuy16,179$854,898
2026-08-14Haas JasonDirectorSell7,138$2.1M
2026-08-14Espinoza OctavioChief Financial OfficerBuy2,074$145,263
2026-08-14Espinoza OctavioChief Financial OfficerBuy2,869$159,947
2026-08-14Espinoza OctavioChief Financial OfficerBuy7,171$410,325
2026-08-14Espinoza OctavioChief Financial OfficerBuy3,348$230,142
2026-08-14Espinoza OctavioChief Financial OfficerSell31,641$9.2M
2026-08-04Reardon AndrewCLO & SecretaryBuy5,000$261,350
2026-08-04Reardon AndrewCLO & SecretarySell105$29,834
2026-08-04Reardon AndrewCLO & SecretarySell33$9,390

Source: SEC Form 4 filings · as of 2026-10-06